Please use this identifier to cite or link to this item:
http://arks.princeton.edu/ark:/88435/dsp0173666763p
Title: | A Commercialization Pathway for RAPID 1.0 – A Novel Diagnostic Platform |
Authors: | Fotopoulos, Niko |
Advisors: | Stock, Jeffry |
Department: | Molecular Biology |
Class Year: | 2021 |
Abstract: | The COVID-19 pandemic has revealed infrastructure issues already present in diagnostic testing. Diagnostics remain costly and largely inaccessible to large segments of the American public. Increased innovation in this industry is a must to provide a new age of at-home, low-cost diagnostic technology options. The de la Fuente Lab at the University of Pennsylvania has created a low-cost and highly accurate diagnostic platform using novel electrochemical detection methodologies. This thesis provides a commercialization plan for Professor de la Fuente’s breakthrough approach to diagnostic testing. I detail a path to market for the technology’s first target for COVID-19 and a plan to extend this technology to other diseases. This begins with a strategy for a series of scientific validation studies that are required for FDA approval for the SARS-CoV-2 diagnostic. Further regulatory strategy is offered to adapt the platform to bacterial STDs, the first diagnostics to be created from this platform technology after the pandemic, along with a business plan to reach these markets both domestically and internationally. A development plan is clearly outlined to provide the estimated costs for each milestone of development, along with strategic partnerships to most quickly bring this device to market. |
URI: | http://arks.princeton.edu/ark:/88435/dsp0173666763p |
Type of Material: | Princeton University Senior Theses |
Language: | en |
Appears in Collections: | Molecular Biology, 1954-2023 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FOTOPOULOS-NIKO-THESIS.pdf | 1.18 MB | Adobe PDF | Request a copy |
Items in Dataspace are protected by copyright, with all rights reserved, unless otherwise indicated.